Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 135 of 1,261
  1. US 11913883

    Highly specific tissue imaging

    The Board of Regents of the University of Texas System Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  2. US 11912986

    Methods for screening genetic perturbations

    The Regents of the University of California Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  3. US 11911368

    Method of treatment of CNS disorders

    Supernus Pharmaceuticals, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  4. US 11911178

    System and method to detect and treat arrhythmogenic regions in atrial fibrillation

    Northwestern University Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  5. US 11911419

    Compositions and methods for treating epilepsy and related disorders

    Finch Therapeutics Holdings LLC Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  6. US 11911515

    Extended release compositions comprising pyridostigmine

    Amneal Complex Products Research LLC Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  7. US 11911415

    CRISPR/Cas-related methods and compositions for improving transplantation

    Editas Medicine, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  8. US 11912695

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  9. US 11911376

    Methods for preventing and treating retinal damage

    The Regents of the University of Colorado Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  10. US 11911435

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  11. US 11912750

    GDNF fusion polypeptides and methods of use thereof

    Keros Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  12. US 11911367

    Methods for treating cancer

    Regents of the University of Minnesota Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  13. US 11912762

    Method of treating osteoarthritis by administering an anti-connexin 43 antibody

    The Board of Regents of the University of Texas System Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  14. US 11911487

    Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods

    United States Government as represented by the Department of Veterans Affairs Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  15. US 11911359

    Stimulation of an immune response by cationic lipids

    PDS Biotechnology Corporation Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  16. US 11912998

    Method of treating aging-associated cognitive impairment by reducing CCR3

    United States Government as represented by the Department of Veterans Affairs Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  17. US 11911403

    Antisense-induced exon exclusion in type VII collagen

    Sarepta Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  18. WO 2024039256

    RÉGIMES THÉRAPEUTIQUES POUR LA MALADIE DE PARKINSON

    BIAL PORTELA & CA SA [PT] Β· Granted Feb 22, 2024 Β· Expires Feb 17, 2044

    granted
  19. US 11903967

    Method of preparing T cells with increased activity

    AUTOLUS LIMITED Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  20. US 11905268

    Anthranilic acid derivatives and their use in the treatment of human cancers

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  21. US 11906519

    Methods for identifying LILRB-blocking antibodies

    The Board of Regents of the University of Texas System Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  22. US 11905327

    Single-domain antibodies and variants thereof against TIGIT

    Nanjing Legend Biotech Co., Ltd Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  23. US 11904025

    Cyclophanes for live-cell imaging

    Northwestern University Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  24. US 11904010

    Recombinant virus capable of stably expressing target proteins

    BOEHRINGER INGELHEIM VETMEDICA (CHINA) CO., LTD. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.